Bristol Myers (Brazil) Market Value
| BMYB34 Stock | BRL 341.31 0.39 0.11% |
| Symbol | Bristol |
Bristol Myers 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Bristol Myers' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Bristol Myers.
| 07/05/2023 |
| 11/26/2024 |
If you would invest 0.00 in Bristol Myers on July 5, 2023 and sell it all today you would earn a total of 0.00 from holding Bristol Myers Squibb or generate 0.0% return on investment in Bristol Myers over 510 days. Bristol Myers is related to or competes with STMicroelectronics, Waste Management, MAHLE Metal, Home Depot, Monster Beverage, and Paycom Software. Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, markets, distributes, and sells biopharmaceuti... More
Bristol Myers Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Bristol Myers' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Bristol Myers Squibb upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 2.39 | |||
| Information Ratio | 0.1431 | |||
| Maximum Drawdown | 15.14 | |||
| Value At Risk | (1.84) | |||
| Potential Upside | 3.9 |
Bristol Myers Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Bristol Myers' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Bristol Myers' standard deviation. In reality, there are many statistical measures that can use Bristol Myers historical prices to predict the future Bristol Myers' volatility.| Risk Adjusted Performance | 0.1662 | |||
| Jensen Alpha | 0.3832 | |||
| Total Risk Alpha | 0.0952 | |||
| Sortino Ratio | 0.1156 | |||
| Treynor Ratio | 3.8 |
Bristol Myers Squibb Backtested Returns
Bristol Myers appears to be very steady, given 3 months investment horizon. Bristol Myers Squibb secures Sharpe Ratio (or Efficiency) of 0.22, which signifies that the company had a 0.22% return per unit of risk over the last 3 months. We have found twenty-nine technical indicators for Bristol Myers Squibb, which you can use to evaluate the volatility of the firm. Please makes use of Bristol Myers' Downside Deviation of 2.39, mean deviation of 1.03, and Risk Adjusted Performance of 0.1662 to double-check if our risk estimates are consistent with your expectations. On a scale of 0 to 100, Bristol Myers holds a performance score of 17. The firm shows a Beta (market volatility) of 0.1, which signifies not very significant fluctuations relative to the market. As returns on the market increase, Bristol Myers' returns are expected to increase less than the market. However, during the bear market, the loss of holding Bristol Myers is expected to be smaller as well. Please check Bristol Myers' downside deviation, standard deviation, total risk alpha, as well as the relationship between the coefficient of variation and jensen alpha , to make a quick decision on whether Bristol Myers' price patterns will revert.
Auto-correlation | -0.08 |
Very weak reverse predictability
Bristol Myers Squibb has very weak reverse predictability. Overlapping area represents the amount of predictability between Bristol Myers time series from 5th of July 2023 to 16th of March 2024 and 16th of March 2024 to 26th of November 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Bristol Myers Squibb price movement. The serial correlation of -0.08 indicates that barely 8.0% of current Bristol Myers price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.08 | |
| Spearman Rank Test | -0.2 | |
| Residual Average | 0.0 | |
| Price Variance | 478.72 |
Bristol Myers Squibb lagged returns against current returns
Autocorrelation, which is Bristol Myers stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Bristol Myers' stock expected returns. We can calculate the autocorrelation of Bristol Myers returns to help us make a trade decision. For example, suppose you find that Bristol Myers has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Bristol Myers regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Bristol Myers stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Bristol Myers stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Bristol Myers stock over time.
Current vs Lagged Prices |
| Timeline |
Bristol Myers Lagged Returns
When evaluating Bristol Myers' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Bristol Myers stock have on its future price. Bristol Myers autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Bristol Myers autocorrelation shows the relationship between Bristol Myers stock current value and its past values and can show if there is a momentum factor associated with investing in Bristol Myers Squibb.
Regressed Prices |
| Timeline |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Information and Resources on Investing in Bristol Stock
When determining whether Bristol Myers Squibb offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Bristol Myers' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Bristol Myers Squibb Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Bristol Myers Squibb Stock:Check out Bristol Myers Correlation, Bristol Myers Volatility and Bristol Myers Alpha and Beta module to complement your research on Bristol Myers. You can also try the Price Transformation module to use Price Transformation models to analyze the depth of different equity instruments across global markets.
Bristol Myers technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.